ARCT
Arcturus Therapeutics Holdings Inc
14.70$
-8.4%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.1% | 73.0% | 99.5% | 97.8% | 94.6% | 90.4% | 98.2% | 96.5% | 89.6% | 90.0% | 88.9% | 89.0% | |
| 9.7% | 23.2% | 4.5% | 48.0% | 83.1% | 86.9% | 97.2% | 94.3% | 87.0% | 68.0% | 68.9% | 85.2% | |
| 97.2% | 70.7% | 97.4% | 93.4% | 83.1% | 86.9% | 97.2% | 94.3% | 87.0% | 68.0% | 68.9% | 85.2% | |
| 0.5% | 0.5% | 7.0% | 0.9% | 10.1% | 2.7% | 0.4% | 0.9% | 0.6% | 7.5% | 1.2% | 2.1% | |
| – | -0.2% | -1.0% | 2.8% | 0.0% | – | – | 0.0% | – | -1.8% | – | – | |
| 0.4% | 0.3% | 2.6% | 2.0% | 4.5% | 9.1% | 0.7% | 2.9% | 10.0% | – | – | – | |
| 10.6% | 3.3% | 8.4% | 35.0% | 69.1% | 68.6% | 16.8% | 41.9% | 40.0% | 35.1% | 30.0% | 21.1% | |
| 10.6% | 3.3% | 8.4% | 21.2% | 28.5% | 26.0% | 10.4% | 25.3% | 28.2% | 19.1% | 19.0% | 13.4% | |
| – | – | 0.3% | – | – | 1.0% | 0.6% | 6.1% | 14.3% | 1.0% | 1.0% | 1.6% | |
| 1.4% | 0.1% | 6.5% | 3.4% | 5.4% | 7.1% | 2.3% | 2.6% | 1.7% | 1.2% | 2.1% | 1.6% | |
| – | – | – | – | 22.4% | 18.3% | 2.9% | 10.3% | – | – | – | – | |
| 89.4% | 96.7% | 91.6% | 65.0% | 30.9% | 31.4% | 83.2% | 58.1% | 60.0% | 64.9% | 70.0% | 78.9% | |
| -231.1% | -99.1% | -185.4% | -44.4% | -101.5% | -87.2% | -30.2% | -88.5% | -75.1% | -85.7% | -130.4% | -189.8% | |
| 8.8% | 4.3% | 7.6% | 5.9% | 22.8% | 14.7% | 4.3% | 6.7% | 6.0% | 6.2% | 7.8% | 10.1% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.